These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Transmission potential of two chimeric Chikungunya vaccine candidates in the urban mosquito vectors, Aedes aegypti and Ae. albopictus. Darwin JR; Kenney JL; Weaver SC Am J Trop Med Hyg; 2011 Jun; 84(6):1012-5. PubMed ID: 21633043 [TBL] [Abstract][Full Text] [Related]
10. Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice. Hallengärd D; Kakoulidou M; Lulla A; Kümmerer BM; Johansson DX; Mutso M; Lulla V; Fazakerley JK; Roques P; Le Grand R; Merits A; Liljeström P J Virol; 2014 Mar; 88(5):2858-66. PubMed ID: 24371047 [TBL] [Abstract][Full Text] [Related]
15. Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218. Edelman R; Tacket CO; Wasserman SS; Bodison SA; Perry JG; Mangiafico JA Am J Trop Med Hyg; 2000 Jun; 62(6):681-5. PubMed ID: 11304054 [TBL] [Abstract][Full Text] [Related]
16. Liposomal Delivery of the RNA Genome of a Live-Attenuated Chikungunya Virus Vaccine Candidate Provides Local, but Not Systemic Protection After One Dose. Abeyratne E; Tharmarajah K; Freitas JR; Mostafavi H; Mahalingam S; Zaid A; Zaman M; Taylor A Front Immunol; 2020; 11():304. PubMed ID: 32194557 [TBL] [Abstract][Full Text] [Related]